17 Jun 2020 --- US-based start-up Biomilq is one step closer to offering mammary cell-cultured human breast milk to families around the globe thanks to US$3.5 million in funding. The funding round was led by Breakthrough Energy Ventures and will allow Biomilq to scale and perfect its production process, expand its team, and collaborate with families, pediatricians and the lactation community. The company is ultimately aiming to have a product that is accessible to a broad consumer market, citing the challenges surrounding this in cell-based products, especially amid COVID-19.